Analysis of racial/ethnic representation in select basic and applied cancer research studies S Guerrero, A López-Cortés, A Indacochea, JM García-Cárdenas, ... Scientific reports 8 (1), 13978, 2018 | 147 | 2018 |
Analysis and implementation of an electronic laboratory notebook in a biomedical research institute S Guerrero, G Dujardin, A Cabrera-Andrade, C Paz-y-Miño, A Indacochea, ... PLoS One 11 (8), e0160428, 2016 | 30 | 2016 |
Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels A Indacochea, S Guerrero, M Ureña, F Araujo, O Coll, ME LLeonart, ... Rna 27 (2), 190-201, 2021 | 27 | 2021 |
Taxane-induced attenuation of the CXCR2/BCL-2 axis sensitizes prostate cancer to platinum-based treatment VR de Porras, XC Wang, L Palomero, M Marin-Aguilera, C Solé-Blanch, ... European urology 79 (6), 722-733, 2021 | 26 | 2021 |
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas O Etxaniz, C Carrato, I de Aguirre, C Queralt, A Muñoz, JL Ramirez, ... Journal of neuro-oncology 135, 273-284, 2017 | 26 | 2017 |
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept J Martinez-Useros, T Georgiev-Hristov, MJ Fernández-Aceñero, ... PLoS One 12 (8), e0182044, 2017 | 19 | 2017 |
Outcome prognostic factors in inoperable malignant bowel obstruction M Romeo, M de los LLanos Gil, JL Cuadra Urteaga, L Vilà, S Ahlal, ... Supportive Care in Cancer 24, 4577-4586, 2016 | 19 | 2016 |
A quick guide for using Microsoft OneNote as an electronic laboratory notebook S Guerrero, A López-Cortés, JM García-Cárdenas, P Saa, A Indacochea, ... PLoS computational biology 15 (5), e1006918, 2019 | 18 | 2019 |
In silico analyses reveal new putative Breast Cancer RNA-binding proteins S Guerrero, A López-Cortés, JM García-Cárdenas, I Armendáriz-Castillo, ... BioRxiv, 2020.01. 08.898965, 2020 | 12 | 2020 |
Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis N Mestre-Farras, S Guerrero, N Bley, E Rivero, O Coll, E Borras, E Sabido, ... Nucleic Acids Research 50 (14), 8207-8225, 2022 | 11 | 2022 |
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker … J García-Corbacho, A Indacochea, AE González Navarro, I Victoria, ... Cancer Immunology, Immunotherapy 72 (6), 1709-1723, 2023 | 8 | 2023 |
Integrated in silico analyses identify PUF60 and SF3A3 as new spliceosome-related breast cancer RNA-binding proteins JM García-Cárdenas, I Armendáriz-Castillo, A Pérez-Villa, A Indacochea, ... Biology 11 (4), 481, 2022 | 6 | 2022 |
Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas JM García-Cárdenas, I Armendáriz-Castillo, N García-Cárdenas, ... Frontiers in Cell and Developmental Biology 11, 1088057, 2023 | 3 | 2023 |
Prevalence of ROS1 translocation, HER2, and BRAF mutations in a cohort of advanced Non-Small Cell Lung Cancer (NSCLC) patients (p) triple negative (TN). E Carcereny Costa, A Estival, LVÃ Martinez, MLGIL Gil Moreno, T Moran, ... Journal of Clinical Oncology 33 (15_suppl), e22139-e22139, 2015 | 2 | 2015 |
Toward equitable precision oncology: monitoring racial and ethnic inclusion in genomics and clinical trials JM García-Cárdenas, A Indacochea, D Pesantez-Coronel, ... JCO Precision Oncology 8, e2300398, 2024 | 1 | 2024 |
125P Assessing the accuracy of multiple prognostic scores for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors J Garcia-Corbacho, A Indacochea, A Gonzalez, IV Ruiz, DM Fernández, ... Annals of Oncology 33, S594-S595, 2022 | 1 | 2022 |
92P First-results of the CLIMB360 study, a prospective molecular screening program across multiple cancer types based on circulating tumor DNA (ctDNA) J Garcia-Corbacho, IV Ruiz, L Angelats, A Indacochea, J Martínez-Vidal, ... Annals of Oncology 32, S396-S397, 2021 | 1 | 2021 |
Genetic profiling across multiple cancer types using molecular prescreening comprehensive gene panels offered by clinical trials (CT). I Victoria, D Moreno Fernandez, L Angelats, A Indacochea, F Pelegrín, ... Journal of Clinical Oncology 39 (15_suppl), 3060-3060, 2021 | 1 | 2021 |
The Molecular Biology of Cancer Disparities JM García-Cárdenas, C Morán-Erazo, E Chávez-Vélez, M Terán-Navas, ... | | 2024 |
487P HER2DX ERBB2 mRNA assay following trastuzumab-based chemotherapy in HER2-positive (HER2+) advanced gastric cancer (AGC) TS Nadal, DSP Coronel, FB Maristany, A Indacochea, M Cuatrecasas, ... Annals of Oncology 35, S194, 2024 | | 2024 |